Skip to main content

Table 1 Baseline characteristics of participants in the CIMWM and TMWM groupsa

From: Effectiveness of companion-intensive multi-aspect weight management in Chinese adults with obesity: a 6-month multicenter randomized clinical trial

 

CIMWM

TMWM

p valueb

Age (years)

31.52 ± 6.43

32.16 ± 6.39

0.427

Sex (M/F)

72/51

77/54

0.969

BMI (kg/m2)

32.36 ± 3.40

32.48 ± 3.59

0.800

BW (kg)

92.77 ± 14.91

92.98 ± 14.08

0.909

BFP (%)

34.60 ± 4.54

35.03 ± 4.72

0.459

BFM (kg)

32.03 ± 6.32

32.61 ± 7.06

0.490

FFM (kg)

60.82 ± 11.14

60.30 ± 9.88

0.689

SMM (kg)

33.30 ± 6.20

33.07 ± 5.49

0.752

VFA (cm2)

133.70 ± 34.46

140.5 ± 48.59

0.205

S/V (kg/cm2)

0.26 ± 0.08

0.27 ± 0.23

0.760

WC (cm)

103.59 ± 11.78

103.70 ± 12.74

0.940

HC (cm)

110.61 ± 7.58

110.34 ± 11.86

0.832

WHR

0.94 ± 0.09

0.99 ± 0.69

0.365

SBP (mmHg)

130.88 ± 12.79

131.73 ± 13.64

0.607

DBP (mmHg)

82.66 ± 10.22

83.75 ± 10.70

0.409

ALT (U/L)

44.79 ± 37.24

38.36 ± 26.57

0.113

AST (U/L)

27.98 ± 14.08

26.02 ± 11.46

0.224

TC (mmol/L)

5.15 ± 1.05

5.09 ± 0.84

0.574

TG (mmol/L)

2.16 ± 1.70

1.98 ± 1.12

0.307

HDL-C (mmol/L)

1.11 ± 0.27

1.22 ± 1.16

0.296

LDL-C (mmol/L)

3.19 ± 0.74

3.17 ± 0.71

0.839

Lp (a) (mg/L)

158.20 ± 172.72

140.05 ± 145.57

0.365

FPG (mmol/L)

5.16 ± 0.75

5.13 ± 1.08

0.763

Cr (µmol/L)

70.25 ± 15.70

67.57 ± 15.71

0.176

UA (µmol/L)

404.12 ± 111.32

389.11 ± 116.72

0.296

FINS (pmol/L)

157.82 ± 198.46

135.32 ± 80.83

0.233

FCP (pmol/L)

1292.20 ± 1201.69

1062.05 ± 454.12

0.048*

HbA1c (%)

5.51 ± 0.42

5.48 ± 0.37

0.516

IFG Number (%)

11(8.9%)

10(7.6%)

0.705

PLT (×109)

267.80 ± 56.57

261.10 ± 60.25

0.363

ALB (g/L)

45.90 ± 4.26

45.48 ± 3.96

0.418

NFS

− 3.12 ± 1.01

− 2.91 ± 1.07

0.111

Fibrosis Severity Scale

  

0.126

 F0–F2

119(96.7%)

121(92.4%)

 Indeterminant score

4(3.3%)

10(7.6%)

 F3–F4

0

0

HOMA-IR

5.16 ± 6.15

4.42 ± 2.78

0.209

  1. BMI Body mass index, BW body weight, BFP body fat percentage, BFM body fat mass, FFM fat-free mass, SMM skeletal muscle mass, VFA visceral fat area, S/V skeletal muscle mass-to-visceral fat area radio, WC waist circumference, HC hip circumference, WHR waist-to-hip ratio, ALT alanine aminotransferase, AST aspartate aminotransferase, TC total cholesterol, TG triglyceride, HDL⁃C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, [Lp(a)] Lipoprotein(a), Cr creatinine, UA uric acid, FPG fasting plasma glucose, FINS fasting insulin, FCP fasting C peptide, PLT platelet, ALB albumin, HbA1c glycated hemoglobin, NFS non-alcoholic fatty liver disease score, IFG impaired fasting glucose, SBP systolic blood pressure, DBP diastolic blood pressure, HOMA-IR homeostasis model assessment of insulin resistance
  2. aData are represented as mean ± SD for continuous variables and as percentages for categorical variables
  3. bIndependent samples t test and chi-square test were used for continuous and categorical variables, respectively
  4. *p < 0.05
Back to article page

Nutrition & Metabolism

ISSN: 1743-7075

Contact us